Search Results - "Opioid use disorder"

A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States by John J. Chiosi, Peter P. Mueller, Jagpreet Chhatwal, Andrea L. Ciaranello

Connect to this object online.

Gender disparities in opioid treatment progress in methadone versus counseling by Erick Guerrero, Hortensia Amaro, Yinfei Kong, Tenie Khachikian, Jeanne C. Marsh

Connect to this object online.

Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study by Gerard Arnoldus Kalkman, Msc, Cornelis Kramers, ProfMD, Robert T van Dongen, PhD, Wim van den Brink, ProfMD, Arnt Schellekens, PhD

Connect to this object online.

Testing for Hepatitis C During Pregnancy Among Persons With Medicaid and Commercial Insurance: Cohort Study by Mohammed A Khan, William W Thompson, Ademola Osinubi, William A Meyer 3rd, Harvey W Kaufman, Paige A Armstrong, Monique A Foster, Noele P Nelson, Carolyn Wester

Connect to this object online.

Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City by Alex S. Bennett, Joy Scheidell, Jeanette M. Bowles, Maria Khan, Alexis Roth, Lee Hoff, Christina Marini, Luther Elliott

Connect to this object online.

Mortality in homeless people enrolled in the French housing first randomized controlled trial: a secondary outcome analysis of predictors and causes of death by Aurélie Tinland, Sandrine Loubiere, Matthieu Cantiello, Mohamed Boucekine, Vincent Girard, Owen Taylor, Pascal Auquier

Connect to this object online.

Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: a mortality data analysis from 2019 to 2022Research in c... by Anne H. Hébert, Alison L. Hill

Connect to this object online.

Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation by Bright D, Saadeh C, DeVuyst-Miller S, Sohn M, Choker A, Langerveld A

Connect to this object online.

Identification of factors associated with opioid-related and hepatitis C virus-related hospitalisations at the ZIP code area level in the USA: an ecological and modelling study by Fatih Gezer, PhD, Kerry A Howard, PhD, Alain H Litwin, ProfMD, Natasha K Martin, ProfPhD, Lior Rennert, PhD

Connect to this object online.

Enhanced recovery protocol after cesarean delivery: impact on opioid use and pain perceptionAJOG MFM at a Glance by Ememobong O. Ubom, MD, Carrie Wang, BA, Farina Klocksieben, MPH, Amanda B. Flicker, MD, Liany Diven, MD, Meredith Rochon, MD, Joanne N. Quiñones, MD, MSCE

Connect to this object online.

How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users by Butler, Stephen F, Oyedele, Natasha K, Dailey Govoni, Taryn, Green, Jody L

Connect to this object online.

Association Between Buprenorphine Dose and the Urine "Norbuprenorphine" to "Creatinine" Ratio: Revised by Hiroko Furo, Timothy Wiegand, Meenakshi Rani, Diane G Schwartz, Ross W Sullivan, Peter L Elkin

Connect to this object online.

A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey by Francisco A. Montiel Ishino, Philip R. McNab, Tamika Gilreath, Bonita Salmeron, Faustine Williams

Connect to this object online.

Implementation of universal screening for substance use in pregnancy in a public healthcare systemAJOG Global Reports at a Glance by Alesha White, MD, Macy Afsari, Harini Balakrishnan, Emilia Chapa, Meredith Kim, Shubhangi Mehra, Mary Ann Faucher, PhD, CNM, FACNM, Joyce Miller, DNP, APRN, WHNP-BC, Polly Cordova, DNP, APRN, CNM, Elaine L. Duryea, MD, David B. Nelson, MD, Anne M. Ambia, MD, Donald D. Mcintire, PhD, Emily H. Adhikari, MD

Connect to this object online.

Public Health in Pharmacy Practice A Casebook by Covvey, Jordan R, Arya, Vibhuti, Mager, Natalie A. DiPietro

Table of Contents: “…A stigma that undermines care: opioid use disorder and treatment considerations -- 39. …”
Access online version

No obvious effect on mortality from a patient choice reform expanding access to opioid disorder treatment - results from a natural experiment of policy change in Sweden by Anders Håkansson, Sahar Janfada-Baloo, Jonas Berge

Connect to this object online.

Identifying Provider Barriers to the Implementation of Opioid Harm Reduction Methods: An Initial Narrative Review by Stacie A. Dee DNP, PMHNP-BC, Ketrice-Ann Delonnay DNP, Destiny Bernard DNP, PMHNP-BC, Fahimir Jean-Baptiste DNP

Connect to this object online.

Factors in rural community buprenorphine dispensing by Erin G. Major, Courtenay Gilmore Wilson, Delesha M. Carpenter, J. Chase Harless, Grace Trull Marley, Bayla Ostrach

Connect to this object online.

Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study by Tongchao Zhang, Lin Sun, Xiaolin Yin, Hui Chen, Lejin Yang, Xiaorong Yang

Connect to this object online.

Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov by Minen, Mia Tova, Reichel, Julia Frederica, Pemmireddy, Pallavi, Loder, Elizabeth, Torous, John

Connect to this object online.